Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Exchange Rate Effect (2020 - 2025)

RxSight's Exchange Rate Effect history spans 6 years, with the latest figure at -$15000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 25.0% year-over-year to -$15000.0; the TTM value through Dec 2025 reached $3000.0, up 133.33%, while the annual FY2025 figure was $3000.0, 133.33% up from the prior year.
  • Exchange Rate Effect reached -$15000.0 in Q4 2025 per RXST's latest filing, down from -$2000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $14000.0 in Q4 2022 to a low of -$15000.0 in Q4 2025.
  • Average Exchange Rate Effect over 5 years is -$950.0, with a median of -$2500.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 1000.0% in 2022, then surged 1500.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$3000.0 in 2021, then skyrocketed by 566.67% to $14000.0 in 2022, then crashed by 42.86% to $8000.0 in 2023, then tumbled by 250.0% to -$12000.0 in 2024, then fell by 25.0% to -$15000.0 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Exchange Rate Effect are -$15000.0 (Q4 2025), -$2000.0 (Q3 2025), and $14000.0 (Q2 2025).